Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.

Sjølie AK, Dodson P, Hobbs FR.

Int J Clin Pract. 2011 Feb;65(2):148-53. doi: 10.1111/j.1742-1241.2010.02552.x. Review.

PMID:
21235695
2.

Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.

Bilous R.

Prim Care Diabetes. 2008 Dec;2(4):201-2. doi: 10.1016/j.pcd.2008.06.002. No abstract available.

PMID:
18760685
3.

Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.

Wright AD, Dodson PM.

Eye (Lond). 2010 Jan;24(1):1-6. doi: 10.1038/eye.2009.189. Review.

PMID:
19648902
4.

Prospects for angiotensin receptor blockers in diabetic retinopathy.

Sjølie AK.

Diabetes Res Clin Pract. 2007 May;76 Suppl 1:S31-9. Review.

PMID:
17321627
5.

The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.

Sjølie AK, Chaturvedi N.

J Hum Hypertens. 2002 Aug;16 Suppl 3:S42-6. Review.

6.

Renin-angiotensin blockade in diabetic retinopathy.

Ghattas A, Lip PL, Lip GY.

Int J Clin Pract. 2011 Feb;65(2):113-6. doi: 10.1111/j.1742-1241.2010.02592.x. No abstract available.

PMID:
21235693
7.

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics.

Sjølie AK, Porta M, Parving HH, Bilous R, Klein R; DIRECT Programme Study Group..

J Renin Angiotensin Aldosterone Syst. 2005 Mar;6(1):25-32.

PMID:
16088848
8.

Primary prevention using losartan in type 1 diabetic patients significantly reduces retinopathy.

[No authors listed]

Cardiovasc J Afr. 2009 Jul-Aug;20(4):265. No abstract available.

9.

The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.

Klein R, Moss SE, Sinaiko AR, Zinman B, Gardiner R, Suissa S, Donnelly SM, Kramer MS, Goodyer P, Strand T, Mauer M.

Ophthalmology. 2006 Dec;113(12):2231-6.

PMID:
16996597
10.
11.

Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R.

N Engl J Med. 2009 Jul 2;361(1):40-51. doi: 10.1056/NEJMoa0808400.

12.
13.

Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Katavetin P, Katavetin P.

N Engl J Med. 2009 Oct 1;361(14):1410-1; author reply 1411. No abstract available.

PMID:
19802919
14.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
15.

Diabetes complications and the renin-angiotensin system.

Perkins BA, Aiello LP, Krolewski AS.

N Engl J Med. 2009 Jul 2;361(1):83-5. doi: 10.1056/NEJMe0904293. No abstract available.

PMID:
19571288
16.

Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.

Harindhanavudhi T, Mauer M, Klein R, Zinman B, Sinaiko A, Caramori ML; Renin Angiotensin System Study (RASS) group..

Diabetes Care. 2011 Aug;34(8):1838-42. doi: 10.2337/dc11-0476.

17.

Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.

Song JH, Cha SH, Lee HJ, Lee SW, Park GH, Lee SW, Kim MJ.

Nephrol Dial Transplant. 2006 Mar;21(3):683-9.

18.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.

Gales BJ, Bailey EK, Reed AN, Gales MA.

Ann Pharmacother. 2010 Feb;44(2):360-6. doi: 10.1345/aph.1M312. Review.

PMID:
20086184
19.

Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Tamsma JT.

N Engl J Med. 2009 Oct 1;361(14):1410; author reply 1411. doi: 10.1056/NEJMc091561. No abstract available.

20.

The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy.

Jeganathan VS.

Curr Pharm Biotechnol. 2011 Mar 1;12(3):392-5. Review.

PMID:
20939795
Items per page

Supplemental Content

Support Center